NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Melanotan II from Xingruida XDR? Mail in a sample (US only) and let us test it.

Test my supply
+3 more ↓
61%
Finnrick rating
#30 of 46 Melanotan II vendors
1 of 2 classifiable tests passed
natural 50% · customers 4.5★ (1)
methodology · Purity focus
Finnrick analysis · Melanotan II

Xingruida XDR's Melanotan II evidence is mixed, with the purity-focused score pulled down by a 99.42% purity miss after an earlier 99.77% pass. Identity and fill looked in range, but sparse testing and a batch-ID gap leave uncertainty.

methodology →
vendor intelligence report
Vendor Intelligence Report: Xingruida XDR

Corporate filings trace a dissolved UK namesake and a live Hong Kong layer without resolving the storefront’s controller. The report also maps shared-hosting overlap with Mammoth Biotech and a brand-keyword WhatsApp doorway network.

38 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.33
79%
24
2
Retatrutide
$0.99
78%
32
3
Ipamorelin
$0.90
73%
3
4
GHK-Cu
$0.08
71%
9
5
Melanotan IIselected
$0.58
61%
2
6
PT-141
-
60%
3
7
Tesamorelin
$2.42
55%
10
8
BPC-157
$1.04
54%
8
9
TB-500
$1.74
43%
3
10
Cagrilintide
$3.38
-
0
12
Semaglutide
$2.14
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%18 Jul 2025: 60%31 Jul 2025: 55%15 Nov 2026: current 61%60%61%Jul 25Nov 26
Showing Melanotan II tests only
Xingruida XDR Melanotan II test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
31 Jul 2025Fail
Tested
lab nameView COA
18 Jul 2025Pass
Tested
lab nameView COA

About Xingruida XDR test results from Finnrick

Xingruida XDR is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 94 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Xingruida XDR peptides in this dataset are BPC-157 (8 tests), GHK-Cu (9 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 94 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Melanotan II from Xingruida XDR? Mail in a sample (US only) and let us test it.

Test my supply